drugset / Trial / NCT04965129
Supplementation of n-3 PUFA in the Modulation of Lean Mass in Patients With Lung Cancer Receiving a High-protein Diet
Unknown
50 enrolled
Federal University of Rio de Janeiro
Institutos Madrileño de Estudios Avanzados IMDEA · collabOncoclínicas · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is conducted to test the hypothesis that patients with lung cancer undergoing treatment with immunotherapy, chemotherapy and tyrosine Kinase Inhibitors receiving a high protein diet and supplemented with fish oil will improve muscle mass, therapeutic response and modulate the intestinal microbiota within a 4 month period.
Timeline
- Start
- 2022-11-15
- Primary completion
- 2024-05
- Completion
- 2025-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fish oil | Other / unclassified | 924 mg | — |
| Subject | Fish oil | Other / unclassified | 2100 mg | — |